|
| 36345568 | Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes. | Cancer | 2023 |
| 37905039 | ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer. | bioRxiv | 2023 |
| 37706534 | In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer". | Oncologist | 2023 |
| 37084789 | Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. | Oncologist | 2023 |
| 36609003 | Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. | Eur Urol | 2023 |
| 36898362 | NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. | J Natl Compr Canc Netw | 2023 |
| 34893859 | Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. | J Natl Cancer Inst | 2022 |
| 35534567 | The distinct impacts of race and genetic ancestry on health. | Nat Med | 2022 |
| 36341236 | For us by us: Instituting mentorship models that credit minoritized medical faculty expertise and lived experience. | Front Med (Lausanne) | 2022 |
| 35131885 | The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35040965 | Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System. | JAMA Netw Open | 2022 |
| 33036065 | Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. | Cancer | 2021 |
| 33892497 | Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men. | J Natl Cancer Inst | 2021 |
| 34964855 | Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis. | JAMA Netw Open | 2021 |
| 32461072 | Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer. | Eur Urol | 2020 |
| 33305100 | The Impact of <sup>18</sup>F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer. | Adv Radiat Oncol | 2020 |
| 32690948 | Prostate cancer reactivates developmental epigenomic programs during metastatic progression. | Nat Genet | 2020 |
| 32380981 | Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential. | BMC Cancer | 2020 |
| 32516030 | The Role of Opioids and Their Receptors in Urological Malignancy: A Review. | J Urol | 2020 |
| 30935383 | Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. | BMC Cancer | 2019 |
| 31244925 | A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer. | Theranostics | 2019 |
| 31123087 | Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression. | Cancer Res | 2019 |
| 30478421 | ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. | Nat Med | 2018 |
| 32670616 | Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis. | Converg Sci Phys Oncol | 2018 |
| 27997745 | Impact of treatment on progression to castration-resistance, metastases, and death in men with localized high-grade prostate cancer. | Cancer Med | 2017 |
| 28493842 | Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate. | Oncotarget | 2017 |
| 27302169 | Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. | Cancer Res | 2016 |
| 26477609 | Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. | Prostate | 2016 |
| 27835867 | Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. | Oncotarget | 2016 |
| 27711225 | Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone. | PLoS One | 2016 |
| 25663004 | Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations. | Prostate | 2015 |
| 28230103 | YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer. | Nat Commun | 2015 |
| 24043735 | Targeting the RANKL pathway: putting the brakes on prostate cancer progression in bone. | J Clin Oncol | 2013 |
| 22610567 | Isolation and characterization of human prostate stem/progenitor cells. | Methods Mol Biol | 2012 |
| 23226620 | Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. | Am J Cancer Res | 2012 |
| 22989880 | Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. | J Biol Chem | 2012 |
| 22930822 | Will identification of a prostate cancer stem cell lead to its cure? | Urol Oncol | 2012 |
| 22880034 | Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. | PLoS One | 2012 |
| 22514625 | Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability. | PLoS One | 2012 |
| 21620777 | Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. | Cancer Cell | 2011 |
| 19070520 | Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. | Urol Oncol | 2010 |
| 20671189 | Identification of a cell of origin for human prostate cancer. | Science | 2010 |
| 20403620 | Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. | J Urol | 2010 |
| 19938015 | Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. | Prostate | 2010 |
| 19022743 | Epithelial stem cells of the prostate and their role in cancer progression. | Cold Spring Harb Symp Quant Biol | 2008 |
| 19088204 | Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. | Proc Natl Acad Sci U S A | 2008 |
| 15368472 | Trefoil factor 3 is overexpressed in human prostate cancer. | Prostate | 2004 |
| 16985591 | Current treatment options for penile fractures. | Rev Urol | 2004 |
| 16985652 | Case scenario: 26-year-old male with right scrotal pain and swelling. | Rev Urol | 2002 |
| 11459831 | Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. | Genes Dev | 2001 |